Solid Biosciences (SLDB)
(Delayed Data from NSDQ)
$6.75 USD
+0.88 (14.99%)
Updated Jul 8, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SLDB 6.75 +0.88(14.99%)
Will SLDB be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SLDB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SLDB
Here's Why Sarepta (SRPT) Stock Price Surged 57% YTD
FDA Expands Sarepta's (SRPT) DMD Gene Therapy Label
SLDB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug
Beat the Market Like Zacks: Walmart, Novo Nordisk, Procter & Gamble in Focus
REGENXBIO (RGNX) Soars 15% on Interim Data From DMD Study
Other News for SLDB
Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Beyond Elevidys: Unveiling The Competitive Landscape Of Duchenne's Muscular Dystrophy
Planet Fitness upgraded, Comcast downgraded: Wall Street's top analyst calls
This Planet Fitness Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Leerink upgrades Solid Biosciences with 'value-creating catalysts' in sight